Research has been the heart of Saint Luke’s for more than 135 years. Our teams strive to continuously improve the quality and value of health care as a national leader in clinical, translational, and outcomes research. Our mission is to advance the prevention and treatment of disease, helping patients live healthier and longer lives.

Saint Luke’s Office of Research Services provides a centralized, comprehensive, service-driven infrastructure that is the foundation for research growth at Saint Luke’s. We offer a wide array of resources and services to help investigators identify and access the information necessary to support their research and team members.

Frequently Asked Questions

What is a clinical study?

A clinical study, also called a clinical trial, is an organized experiment performed on human participants to answer a specific scientific question. Clinical studies are done to:

  • Determine the best way to treat, diagnose, or prevent a disease
  • Answer questions about safety and effectiveness
  • Evaluate whether clinicians are using the best treatments
  • Help the U.S. Food and Drug Administration (FDA) determine whether to approve a treatment for general use

The information learned from clinical studies helps to improve the medical care for future patients.

What are the different types of clinical trials?
  • Treatment trials: Test experimental treatments, new combinations of drugs, or new approaches to surgery or radiation therapy
  • Prevention trials: Look for better ways to prevent disease in people who have never had the disease or to prevent a disease from returning
  • Diagnostic trials: Find better tests or procedures for diagnosing a particular disease or condition
  • Screening trials: Test the best way to detect certain diseases or health conditions
  • Quality of life trials: Explore ways to improve comfort and the quality of life for individuals with a chronic illness
Why are clinical trials important?

The goal of clinical trials is to determine if these treatment, prevention, and behavior approaches are safe and effective. People take part in clinical trials for many reasons. Healthy volunteers may participate to help others and move health care forward. People with an illness or disease take part to help others, but also to possibly receive the newest treatment. Clinical trials offer hope for many people and are an opportunity to help researchers find better treatments.

Learn more about the basics of clinical trial from the Office for Human Research Protections (OHRP) and the National Institutes of Health.


Human Research Protection Program

Saint Luke's Human Research Protection Program's mission is to protect the rights and welfare of individuals who participate in research conducted within Saint Luke's while advocating the advancement of scientific knowledge.


For Researchers and Clinicians

Saint Luke's Office of Research Services provides a centralized, comprehensive, service-driven infrastructure that is the foundation for research growth at Saint Luke’s.


Support Advanced Research

Donor generosity enables our health system to investigate, identify, and provide the safest, innovative technologies and state-of-the-art treatments.

News

Feb. 24, 2025

GLP-1 Medications Associated with Improving Addictive Behaviors

Dr. James O’Keefe, a co-investigator of this study, explains why GLP-1 medications may be uniquely effective in addressing addictive behaviors like recreational drug use, alcohol consumption, and food cravings.
Dec. 19, 2024

Higher Omega-3 Levels Associated with Improved Cardiovascular Outcomes

According to a new study, higher omega-3 levels significantly reduce the risk of heart failure and heart failure fatalities.
Nov. 21, 2024

Healio: Potassium Binder Helps Optimize Spironolactone Use in Patients with HF, Hyperkalemia Risk

A potassium binder helped patients with heart failure who have or are at high risk for hyperkalemia stay on spironolactone at an optimal dose, but showed a signal of HF hospitalization risk.
Nov. 19, 2024

KSHB: Saint Luke's Leads Groundbreaking AFib Treatment

Dr. Sanjaya Gupta spoke to KSHB about pulsed field ablation, as well as the second Saint Luke's patient to undergo this innovative new procedure to treat AFib.
Nov. 15, 2024

Health News You Can Use: Saint Luke’s Muriel I. Kauffman Institute for Women’s Cardiovascular Research

The new Saint Luke’s Muriel I. Kauffman Institute for Women’s Cardiovascular Research is the first of its kind dedicated to studying unique aspects of heart conditions in women.
Nov. 12, 2024

Medical Xpress: Bystander CPR up to 10 Minutes After Cardiac Arrest May Protect Brain Function

New research shows the sooner a lay rescuer starts CPR on a person having a cardiac arrest at home or in public, the better the chances of saving the person's life and protecting their brain function.